$2.93
0.69% yesterday
Nasdaq, Aug 11, 10:05 pm CET

BioNano Genomics, Inc. Stock price

$2.93
-0.47 13.82% 1M
-2.47 45.74% 6M
-14.37 83.07% YTD
-20.68 87.59% 1Y
-2,025.07 99.86% 3Y
-475.93 99.39% 5Y
-4,191.07 99.93% 10Y
-4,191.07 99.93% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.02 0.69%

Key metrics

Basic
Market capitalization
$9.9m
Enterprise Value
$-4.6m
Net debt
positive
Cash
$18.2m
Shares outstanding
3.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.3 | 0.3
EV/Sales
negative | negative
EV/FCF
0.1
P/B
0.2
Financial Health
Equity Ratio
46.1%
Return on Equity
-316.7%
ROCE
-112.9%
ROIC
-151.0%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$28.5m | $30.7m
EBITDA
$-45.1m | $-13.6m
EBIT
$-58.7m | $-30.3m
Net Income
$-83.7m | $-22.9m
Free Cash Flow
$-43.6m
Growth (TTM | estimate)
Revenue
-24.1% | -0.3%
EBITDA
60.1% | 80.5%
EBIT
53.6% | 60.3%
Net Income
63.1% | 79.6%
Free Cash Flow
64.3%
Margin (TTM | estimate)
Gross
1.7%
EBITDA
-158.3% | -44.4%
EBIT
-206.2%
Net
-294.1% | -74.6%
Free Cash Flow
-153.3%
More
EPS
$-31.1
FCF per Share
$-14.1
Short interest
12.3%
Employees
99
Rev per Employee
$310.0k
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BioNano Genomics, Inc. forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a BioNano Genomics, Inc. forecast:

Buy
70%
Hold
30%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
28 28
24% 24%
100%
- Direct Costs 28 28
3% 3%
98%
0.49 0.49
95% 95%
2%
- Selling and Administrative Expenses 42 42
52% 52%
147%
- Research and Development Expense 17 17
65% 65%
61%
-45 -45
60% 60%
-158%
- Depreciation and Amortization 14 14
1% 1%
48%
EBIT (Operating Income) EBIT -59 -59
54% 54%
-206%
Net Profit -84 -84
63% 63%
-294%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) and colleagues from multiple French pediatric hematology centers showing how optical genome mapping (OGM) can be used to detect oncogenic structural variants (SVs) in clinical research of i...
Neutral
GlobeNewsWire
6 days ago
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025.
Neutral
GlobeNewsWire
11 days ago
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress.
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 99
Founded 2003
Website bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today